(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

122019017259

ConcedidaUtility ModelPCT · US2012054309

Application data

Number

122019017259

Type

Utility Model

Filing

09/07/2012

Publication

-

PCT

US2012054309

Progress at the INPI

  1. Filing09/07/12
  2. Publication
  3. Examination
  4. Allowance03/03/22
  5. Grant05/10/22
  6. In force09/07/27

The patent was granted on 05/10/2022 and is in force until 09/07/2027. Until then, no one may make, use or sell the invention in Brazil without the owner's authorisation.

Protection valid until:09/07/2027

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 05/10/2022. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

LANTHEUS MEDICAL IMAGING, INC.

US

See this company's full portfolio

Inventors

A. P. (pessoa física)

US

C. H. (pessoa física)

US

D. O. (pessoa física)

US

D. C. (pessoa física)

US

H. R. (pessoa física)

US

M. B. (pessoa física)

US

M. Y. (pessoa física)

US

R. C. (pessoa física)

US

S. R. (pessoa física)

US

T. H. (pessoa física)

US

Technical data

Priority claims

US

61/533,133 · 09/09/2011

US

61/656,489 · 06/06/2012

US

61/656,492 · 06/06/2012

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Concessão da patente

#16.1

Prazo de Validade: 20 (vinte) anos contados a partir de 07/09/2012, observadas as condições legais

05/10/2022

RPI 2679

Deferimento

#9.1

03/03/2022

RPI 2669

Exigência - art. 36 da LPI

#6.1

10/26/2021

RPI 2651

Notificação de pedido dividido

#2.4

Dividido do PCT 11 2014 005286-7

10/01/2019

RPI 2543

Requerimento de pedido de patente

#2.10

Número de Protocolo '870190080543' em 19/08/2019 17:12 (WB)

08/27/2019

RPI 2538

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.